Biomarin Pharmaceutical Inc (BMRN)

Return on assets (ROA)

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Net income (ttm)	US$ in thousands	205,455	167,645	147,021	99,991	71,615	141,561	83,912	54,070	39,347	-64,080	10,846	832,143	790,019	854,029	852,025	122,258	114,006	-23,848	-42,522	-110,178
Total assets	US$ in thousands	6,872,670	6,841,600	6,758,160	6,563,170	6,433,700	6,375,070	6,264,040	6,145,840	6,062,710	6,004,770	5,977,480	5,898,500	5,805,050	5,848,020	6,158,090	5,302,110	4,722,840	4,690,040	4,558,130	4,393,380
ROA		2.99%	2.45%	2.18%	1.52%	1.11%	2.22%	1.34%	0.88%	0.65%	-1.07%	0.18%	14.11%	13.61%	14.60%	13.84%	2.31%	2.41%	-0.51%	-0.93%	-2.51%

March 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $205,455K ÷ $6,872,670K
= 2.99%

Biomarin Pharmaceutical Inc's return on assets (ROA) has demonstrated volatility over the historical period provided. The ROA has ranged from negative figures to double-digit percentages, indicating fluctuations in the company's ability to generate profits relative to its assets.

The ROA has generally been positive, with the highest values observed in the most recent quarters, indicating improved efficiency in utilizing assets to generate profits. The trend of increasing ROA from negative figures in early 2022 to positive values in 2023 and further improvement in 2024 suggests enhanced asset utilization efficiency and profitability.

However, it is worth noting that there were periods of lower ROA, particularly in the middle of the historical period, which may indicate challenges or inefficiencies in asset management and profit generation during those quarters.

In conclusion, Biomarin Pharmaceutical Inc's ROA has shown variability over the historical period, with recent quarters reflecting an improvement in asset efficiency and profitability. Monitoring future ROA trends will be crucial in assessing the company's ongoing performance in terms of generating profits from its assets.